Sherylanne Newton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sherylanne Newton has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Michael R. Bowl
UCL Ear Institute, University College London, London, UK
4 shared publications Andrew Parker
Medical Research Council Harwell Institute
3 shared publications- Adam J. Carlton
School of Biosciences University of Sheffield Sheffield UK
2 shared publications Carlos Aguilar
UCL Ear Institute, University College London, 332 Gray’s Inn Road, London, UK
2 shared publications- Carlos Aguilar
UCL Ear Institute, University College London, London, UK
2 shared publications - Fanbo Kong
Affiliation School of Sciences, University of Sheffield, Sheffield, United Kingdom
2 shared publications
Latest Publications
- Open Access
Monoclonal antibodies for detecting collagen IV α3α4α5 in basement membranes
The collagen IV α3α4α5 trimer forms a specialised network within basement membranes that is essential for normal kidney, inner ear and ocular function. Variants in COL4A3, COL4A4 or COL4A5 disrupt this network and cause Alport syndrome. Yet, current antibody tools detect individual collagen IV chains rather than the assembled α3α4α5 trimer. Here, we generated a recombinant human mini-COL4A345 trimer and used it to produce mouse monoclonal antibodies that recognise native collagen IV α3α4α5. We screened hybridomas using biolayer interferometry, native dot blotting, denaturing western blotting and immunofluorescence, followed by characterisation of selected purified antibodies using surface plasmon resonance. Three clones, Ms5, Ms44 and Ms72, detected native, folded collagen IV α3α4α5. We validated antibody specificity using Col4a3, Col4a5 and Col4a6 knockout mouse tissues, and assessed their utility for human kidney immunofluorescence and immunoprecipitation from mouse kidney. The antibodies detected conformationally intact collagen IV α3α4α5 in tissue, with no detectable cross-reactivity with collagen IV α1α1α2 or α5α5α6 networks under the conditions tested. Clone Ms72 provided the strongest and most consistent tissue signal, localising collagen IV α3α4α5 to the glomerular basement membrane, cochlear basement membranes and retinal pigment epithelium-associated basement membrane. Ms72 also immunoprecipitated endogenous collagen IV α3, α4 and α5 from wild-type kidney tissue, confirming recognition of the native complex. These monoclonal antibodies provide a resource for detecting collagen IV α3α4α5 in basement membrane networks. Their potential applications include assessment of the α3α4α5 heterotrimer in patient biopsies and evaluation of gene therapies and other interventions aimed at modulating α3α4α5 deposition in Alport syndrome.
Open AccessMonoclonal antibodies for detecting collagen IV α3α4α5 in basement membranes
The collagen IV α3α4α5 trimer forms a specialised network within basement membranes that is essential for normal kidney, inner ear and ocular function. Variants in COL4A3, COL4A4 or COL4A5 disrupt this network and cause Alport syndrome. Yet, current antibody tools detect individual collagen IV chains rather than the assembled α3α4α5 trimer. Here, we generated a recombinant human mini-COL4A345 trimer and used it to produce mouse monoclonal antibodies that recognise native collagen IV α3α4α5. We screened hybridomas using biolayer interferometry, native dot blotting, denaturing western blotting and immunofluorescence, followed by characterisation of selected purified antibodies using surface plasmon resonance. Three clones, Ms5, Ms44 and Ms72, detected native, folded collagen IV α3α4α5. We validated antibody specificity using Col4a3, Col4a5 and Col4a6 knockout mouse tissues, and assessed their utility for human kidney immunofluorescence and immunoprecipitation from mouse kidney. The antibodies detected conformationally intact collagen IV α3α4α5 in tissue, with no detectable cross-reactivity with collagen IV α1α1α2 or α5α5α6 networks under the conditions tested. Clone Ms72 provided the strongest and most consistent tissue signal, localising collagen IV α3α4α5 to the glomerular basement membrane, cochlear basement membranes and retinal pigment epithelium-associated basement membrane. Ms72 also immunoprecipitated endogenous collagen IV α3, α4 and α5 from wild-type kidney tissue, confirming recognition of the native complex. These monoclonal antibodies provide a resource for detecting collagen IV α3α4α5 in basement membrane networks. Their potential applications include assessment of the α3α4α5 heterotrimer in patient biopsies and evaluation of gene therapies and other interventions aimed at modulating α3α4α5 deposition in Alport syndrome.
- Open Access
The mouse Cdh23 ahl allele drives early cochlear dysfunction and phenotypic heterogeneity before progressive hearing loss
The Cdh23 ahl allele is present in many commonly used inbred mouse strains and is known to cause progressive hearing loss. However, increasing evidence suggests Cdh23 ahl can also modify the severity and expressivity of other genetic phenotypes, extending its biological effects beyond the cochlea. Here, we define the phenotypic, physiological, and molecular consequences associated with Cdh23 ahl by comparing C57BL/6N mice with a co-isogenic strain in which the allele was repaired by genome editing. We find the auditory phenotype begins earlier and is more variable than generally appreciated, with significant threshold elevations at 36–42 kHz already present by 1-month of age and progressive involvement of lower frequencies thereafter. Before these threshold elevations, inner hair cells at postnatal day 14 (P14) exhibit tonotopically distinct alterations in mechanoelectrical transduction, with reduced maximal transduction currents apically, but increased currents basally, while resting open probability and adaptation kinetics remain preserved. Cochlear transcription is also altered shortly after hearing onset: by P16, Cdh23 ahl and repaired cochleae occupy distinct transcriptional states. By P30, transcriptional differences have expanded substantially, and Cdh23 ahl cochleae show significantly increased inter-individual transcriptomic dispersion coincident with the emergence of variable high-frequency auditory dysfunction. These findings demonstrate that Cdh23 ahl is not physiologically benign in young mice, but is associated with an altered cochlear state that precedes hearing loss. The early and variable consequences of this common allele provide a potential framework for understanding its effects on phenotype expressivity and have important implications for the design and interpretation of studies using mouse strains that carry Cdh23 ahl . Summary: The Cdh23 ahl allele, common to several mouse strains, is known to cause progressive hearing loss, but it can also modify other genetic phenotypes. Using C57BL/6N mice, and a co-isogenic strain in which Cdh23 ahl was repaired, the biological effects of Cdh23 ahl were investigated. Results show the Cdh23 ahl allele causes tonotopically distinct alterations in inner hair cell mechanotransduction and progressive changes in the cochlear transcriptome, leading to a variable auditory phenotype. The findings demonstrate Cdh23 ahl is not a simple loss-of-function allele and provide insight into its ability to modify phenotype severity and expressivity, which has broad implications for studies employing Cdh23 ahl -carrying strains.
Open AccessThe mouse Cdh23 ahl allele drives early cochlear dysfunction and phenotypic heterogeneity before progressive hearing loss
The Cdh23 ahl allele is present in many commonly used inbred mouse strains and is known to cause progressive hearing loss. However, increasing evidence suggests Cdh23 ahl can also modify the severity and expressivity of other genetic phenotypes, extending its biological effects beyond the cochlea. Here, we define the phenotypic, physiological, and molecular consequences associated with Cdh23 ahl by comparing C57BL/6N mice with a co-isogenic strain in which the allele was repaired by genome editing. We find the auditory phenotype begins earlier and is more variable than generally appreciated, with significant threshold elevations at 36–42 kHz already present by 1-month of age and progressive involvement of lower frequencies thereafter. Before these threshold elevations, inner hair cells at postnatal day 14 (P14) exhibit tonotopically distinct alterations in mechanoelectrical transduction, with reduced maximal transduction currents apically, but increased currents basally, while resting open probability and adaptation kinetics remain preserved. Cochlear transcription is also altered shortly after hearing onset: by P16, Cdh23 ahl and repaired cochleae occupy distinct transcriptional states. By P30, transcriptional differences have expanded substantially, and Cdh23 ahl cochleae show significantly increased inter-individual transcriptomic dispersion coincident with the emergence of variable high-frequency auditory dysfunction. These findings demonstrate that Cdh23 ahl is not physiologically benign in young mice, but is associated with an altered cochlear state that precedes hearing loss. The early and variable consequences of this common allele provide a potential framework for understanding its effects on phenotype expressivity and have important implications for the design and interpretation of studies using mouse strains that carry Cdh23 ahl . Summary: The Cdh23 ahl allele, common to several mouse strains, is known to cause progressive hearing loss, but it can also modify other genetic phenotypes. Using C57BL/6N mice, and a co-isogenic strain in which Cdh23 ahl was repaired, the biological effects of Cdh23 ahl were investigated. Results show the Cdh23 ahl allele causes tonotopically distinct alterations in inner hair cell mechanotransduction and progressive changes in the cochlear transcriptome, leading to a variable auditory phenotype. The findings demonstrate Cdh23 ahl is not a simple loss-of-function allele and provide insight into its ability to modify phenotype severity and expressivity, which has broad implications for studies employing Cdh23 ahl -carrying strains.
- Open Access
- 1 September 2026
- Published by Springer Nature in Research Square
Multivariate analysis of a large-scale auditory screen reveals new candidate hearing loss genes
Early-onset hearing loss (HL) occurs in ~ 1 in 500 babies, with genetic factors thought to account for ~ 80% of prelingual HL cases. Hereditary HL is highly heterogenous, with > 100 genes identified as critical for hearing. However, most patients remain undiagnosed after genetic testing, suggesting that many more hearing essential genes are yet to be identified. The International Mouse Phenotyping Consortium (IMPC) provides an unparalleled resource for ‘hearing’ gene discovery, with > 6,700 mouse knockouts assessed by auditory brainstem response (ABR) testing. However, the current frequency-by-frequency univariate analyses applied to ABR measurements limit the sensitivity and specificity of current IMPC auditory phenotyping. Here, integrating multivariate, Bayesian, and clustering approaches to interrogate the IMPC datasets, we identify 133 genes with evidence for HL, of which 59 are novel associations. Importantly, 16 of the 59 genes are not identified by the statistical pipeline used by the IMPC. We also apply unsupervised clustering to derive data-driven audiometric phenotypes, revealing recurrent patterns suggestive of shared underlying mechanisms. Moreover, we validate two candidate genes, Tmem51 and Nedd4l . Our analyses demonstrate the IMPC remains a valuable resource for the identification of novel deafness genes and provide a methodological framework that could be applied across other large-scale phenotyping pipelines.
- 1 September 2026
- Published by Springer Nature in Research Square
Open AccessMultivariate analysis of a large-scale auditory screen reveals new candidate hearing loss genes
Early-onset hearing loss (HL) occurs in ~ 1 in 500 babies, with genetic factors thought to account for ~ 80% of prelingual HL cases. Hereditary HL is highly heterogenous, with > 100 genes identified as critical for hearing. However, most patients remain undiagnosed after genetic testing, suggesting that many more hearing essential genes are yet to be identified. The International Mouse Phenotyping Consortium (IMPC) provides an unparalleled resource for ‘hearing’ gene discovery, with > 6,700 mouse knockouts assessed by auditory brainstem response (ABR) testing. However, the current frequency-by-frequency univariate analyses applied to ABR measurements limit the sensitivity and specificity of current IMPC auditory phenotyping. Here, integrating multivariate, Bayesian, and clustering approaches to interrogate the IMPC datasets, we identify 133 genes with evidence for HL, of which 59 are novel associations. Importantly, 16 of the 59 genes are not identified by the statistical pipeline used by the IMPC. We also apply unsupervised clustering to derive data-driven audiometric phenotypes, revealing recurrent patterns suggestive of shared underlying mechanisms. Moreover, we validate two candidate genes, Tmem51 and Nedd4l . Our analyses demonstrate the IMPC remains a valuable resource for the identification of novel deafness genes and provide a methodological framework that could be applied across other large-scale phenotyping pipelines.
- Open Access
- 5 May 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Kv3.3 subunits control presynaptic action potential waveform and neurotransmitter release at a central excitatory synapse
Kv3 potassium currents mediate rapid repolarisation of action potentials (APs), supporting fast spikes and high repetition rates. Of the four Kv3 gene family members, Kv3.1 and Kv3.3 are highly expressed in the auditory brainstem and we exploited this to test for subunit-specific roles at the calyx of Held presynaptic terminal in the mouse. Deletion of Kv3.3 (but not Kv3.1) reduced presynaptic Kv3 channel immunolabelling, increased presynaptic AP duration and facilitated excitatory transmitter release; which in turn enhanced short-term depression during high-frequency transmission. The response to sound was delayed in the Kv3.3KO, with higher spontaneous and lower evoked firing, thereby reducing signal-to-noise ratio. Computational modelling showed that the enhanced EPSC and short-term depression in the Kv3.3KO reflected increased vesicle release probability and accelerated activity-dependent vesicle replenishment. We conclude that Kv3.3 mediates fast repolarisation for short precise APs, conserving transmission during sustained high-frequency activity at this glutamatergic excitatory synapse.
- 5 May 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Open AccessKv3.3 subunits control presynaptic action potential waveform and neurotransmitter release at a central excitatory synapse
Kv3 potassium currents mediate rapid repolarisation of action potentials (APs), supporting fast spikes and high repetition rates. Of the four Kv3 gene family members, Kv3.1 and Kv3.3 are highly expressed in the auditory brainstem and we exploited this to test for subunit-specific roles at the calyx of Held presynaptic terminal in the mouse. Deletion of Kv3.3 (but not Kv3.1) reduced presynaptic Kv3 channel immunolabelling, increased presynaptic AP duration and facilitated excitatory transmitter release; which in turn enhanced short-term depression during high-frequency transmission. The response to sound was delayed in the Kv3.3KO, with higher spontaneous and lower evoked firing, thereby reducing signal-to-noise ratio. Computational modelling showed that the enhanced EPSC and short-term depression in the Kv3.3KO reflected increased vesicle release probability and accelerated activity-dependent vesicle replenishment. We conclude that Kv3.3 mediates fast repolarisation for short precise APs, conserving transmission during sustained high-frequency activity at this glutamatergic excitatory synapse.
- Open Access
- 31 January 2022
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 18 (1) , e1009937
Neuroplastin genetically interacts with Cadherin 23 and the encoded isoform Np55 is sufficient for cochlear hair cell function and hearing
Mammalian hearing involves the mechanoelectrical transduction (MET) of sound-induced fluid waves in the cochlea. Essential to this process are the specialised sensory cochlear cells, the inner (IHCs) and outer hair cells (OHCs). While genetic hearing loss is highly heterogeneous, understanding the requirement of each gene will lead to a better understanding of the molecular basis of hearing and also to therapeutic opportunities for deafness. The Neuroplastin (Nptn) gene, which encodes two protein isoforms Np55 and Np65, is required for hearing, and homozygous loss-of-function mutations that affect both isoforms lead to profound deafness in mice. Here we have utilised several distinct mouse models to elaborate upon the spatial, temporal, and functional requirement of Nptn for hearing. While we demonstrate that both Np55 and Np65 are present in cochlear cells, characterisation of a Np65-specific mouse knockout shows normal hearing thresholds indicating that Np65 is functionally redundant for hearing. In contrast, we find that Nptn-knockout mice have significantly reduced maximal MET currents and MET channel open probabilities in mature OHCs, with both OHCs and IHCs also failing to develop fully mature basolateral currents. Furthermore, comparing the hearing thresholds and IHC synapse structure of Nptn-knockout mice with those of mice that lack Nptn only in IHCs and OHCs shows that the majority of the auditory deficit is explained by hair cell dysfunction, with abnormal afferent synapses contributing only a small proportion of the hearing loss. Finally, we show that continued expression of Neuroplastin in OHCs of adult mice is required for membrane localisation of Plasma Membrane Ca2+ ATPase 2 (PMCA2), which is essential for hearing function. Moreover, Nptn haploinsufficiency phenocopies Atp2b2 (encodes PMCA2) mutations, with heterozygous Nptn-knockout mice exhibiting hearing loss through genetic interaction with the Cdh23ahl allele. Together, our findings provide further insight to the functional requirement of Neuroplastin for mammalian hearing.
- 31 January 2022
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 18 (1) , e1009937
Open AccessNeuroplastin genetically interacts with Cadherin 23 and the encoded isoform Np55 is sufficient for cochlear hair cell function and hearing
Mammalian hearing involves the mechanoelectrical transduction (MET) of sound-induced fluid waves in the cochlea. Essential to this process are the specialised sensory cochlear cells, the inner (IHCs) and outer hair cells (OHCs). While genetic hearing loss is highly heterogeneous, understanding the requirement of each gene will lead to a better understanding of the molecular basis of hearing and also to therapeutic opportunities for deafness. The Neuroplastin (Nptn) gene, which encodes two protein isoforms Np55 and Np65, is required for hearing, and homozygous loss-of-function mutations that affect both isoforms lead to profound deafness in mice. Here we have utilised several distinct mouse models to elaborate upon the spatial, temporal, and functional requirement of Nptn for hearing. While we demonstrate that both Np55 and Np65 are present in cochlear cells, characterisation of a Np65-specific mouse knockout shows normal hearing thresholds indicating that Np65 is functionally redundant for hearing. In contrast, we find that Nptn-knockout mice have significantly reduced maximal MET currents and MET channel open probabilities in mature OHCs, with both OHCs and IHCs also failing to develop fully mature basolateral currents. Furthermore, comparing the hearing thresholds and IHC synapse structure of Nptn-knockout mice with those of mice that lack Nptn only in IHCs and OHCs shows that the majority of the auditory deficit is explained by hair cell dysfunction, with abnormal afferent synapses contributing only a small proportion of the hearing loss. Finally, we show that continued expression of Neuroplastin in OHCs of adult mice is required for membrane localisation of Plasma Membrane Ca2+ ATPase 2 (PMCA2), which is essential for hearing function. Moreover, Nptn haploinsufficiency phenocopies Atp2b2 (encodes PMCA2) mutations, with heterozygous Nptn-knockout mice exhibiting hearing loss through genetic interaction with the Cdh23ahl allele. Together, our findings provide further insight to the functional requirement of Neuroplastin for mammalian hearing.
- Open Access
Neuroplastin genetically interacts with Cadherin 23 and the encoded isoform Np55 is sufficient for cochlear hair cell function and hearing
Mammalian hearing involves the mechanoelectrical transduction (MET) of sound-induced fluid waves in the cochlea. Essential to this process are the specialised sensory cochlear cells, the inner (IHCs) and outer hair cells (OHCs). While genetic hearing loss is highly heterogeneous, understanding the requirement of each gene will lead to a better understanding of the molecular basis of hearing and also to therapeutic opportunities for deafness. The Neuroplastin ( Nptn ) gene, which encodes two protein isoforms Np55 and Np65, is required for hearing, and homozygous loss-of-function mutations that affect both isoforms lead to profound deafness in mice. Here we have utilised several distinct mouse models to elaborate upon the spatial, temporal, and functional requirement of Nptn for hearing. While we demonstrate that both Np55 and Np65 are present in cochlear cells, characterisation of a Np65-specific mouse knockout shows normal hearing thresholds indicating that Np65 is functionally redundant for hearing. In contrast, we find that Nptn -knockout mice have significantly reduced maximal MET currents and MET channel open probabilities in mature OHCs, with both OHCs and IHCs also failing to develop fully mature basolateral currents. Furthermore, comparing the hearing thresholds and IHC synapse structure of Nptn -knockout mice with those of mice that lack Nptn only in IHCs and OHCs shows that the majority of the auditory deficit is explained by hair cell dysfunction, with abnormal afferent synapses contributing only a small proportion of the hearing loss. Finally, we show that continued expression of NEUROPLASTIN in OHCs of adult mice is required for membrane localisation of Plasma Membrane Ca 2+ ATPase 2 (PMCA2), which is essential for hearing function. Moreover, Nptn haploinsufficiency phenocopies Atp2b2 (encodes PMCA2) mutations, with heterozygous Nptn -knockout mice exhibiting hearing loss through genetic interaction with the Cdh23 ahl allele. Together, our findings provide further insight to the functional requirement of Neuroplastin for mammalian hearing. Author Summary: Sensorineural hearing loss, caused by problems with sensory cells in the cochlea or the auditory nerve, is the most common type of hearing loss. Mutations in Neuroplastin have already been implicated in deafness in mice. We have used mutant mouse models to investigate where Neuroplastin is expressed in the cochlea and its function. When mice do not express a functioning copy of Neuroplastin they have disruptions to the primary sensory synapse. We show that although synaptic disruption contributes to the loss of hearing function it is not the primary cause. Instead, continued expression of Neuroplastin is needed to maintain the localisation of Plasma Membrane Ca 2+ ATPase 2 channels which help regulate calcium flow. We have also shown that two types of NEUROPLASTIN protein (isoforms) are both expressed within the cochlea, although only one of these isoforms needs to be expressed for normal hearing. Finally, we also demonstrate that the hearing loss caused by the absence of Neuroplastin is made worse when combined with a common mutation within a gene called Cadherin 23 ( Cdh23 ahl ). This is an important finding as although there are currently no human patients with an identified NEUROPLASTIN mutation, it may be involved in human deafness in combination with other mutations.
Open AccessNeuroplastin genetically interacts with Cadherin 23 and the encoded isoform Np55 is sufficient for cochlear hair cell function and hearing
Mammalian hearing involves the mechanoelectrical transduction (MET) of sound-induced fluid waves in the cochlea. Essential to this process are the specialised sensory cochlear cells, the inner (IHCs) and outer hair cells (OHCs). While genetic hearing loss is highly heterogeneous, understanding the requirement of each gene will lead to a better understanding of the molecular basis of hearing and also to therapeutic opportunities for deafness. The Neuroplastin ( Nptn ) gene, which encodes two protein isoforms Np55 and Np65, is required for hearing, and homozygous loss-of-function mutations that affect both isoforms lead to profound deafness in mice. Here we have utilised several distinct mouse models to elaborate upon the spatial, temporal, and functional requirement of Nptn for hearing. While we demonstrate that both Np55 and Np65 are present in cochlear cells, characterisation of a Np65-specific mouse knockout shows normal hearing thresholds indicating that Np65 is functionally redundant for hearing. In contrast, we find that Nptn -knockout mice have significantly reduced maximal MET currents and MET channel open probabilities in mature OHCs, with both OHCs and IHCs also failing to develop fully mature basolateral currents. Furthermore, comparing the hearing thresholds and IHC synapse structure of Nptn -knockout mice with those of mice that lack Nptn only in IHCs and OHCs shows that the majority of the auditory deficit is explained by hair cell dysfunction, with abnormal afferent synapses contributing only a small proportion of the hearing loss. Finally, we show that continued expression of NEUROPLASTIN in OHCs of adult mice is required for membrane localisation of Plasma Membrane Ca 2+ ATPase 2 (PMCA2), which is essential for hearing function. Moreover, Nptn haploinsufficiency phenocopies Atp2b2 (encodes PMCA2) mutations, with heterozygous Nptn -knockout mice exhibiting hearing loss through genetic interaction with the Cdh23 ahl allele. Together, our findings provide further insight to the functional requirement of Neuroplastin for mammalian hearing. Author Summary: Sensorineural hearing loss, caused by problems with sensory cells in the cochlea or the auditory nerve, is the most common type of hearing loss. Mutations in Neuroplastin have already been implicated in deafness in mice. We have used mutant mouse models to investigate where Neuroplastin is expressed in the cochlea and its function. When mice do not express a functioning copy of Neuroplastin they have disruptions to the primary sensory synapse. We show that although synaptic disruption contributes to the loss of hearing function it is not the primary cause. Instead, continued expression of Neuroplastin is needed to maintain the localisation of Plasma Membrane Ca 2+ ATPase 2 channels which help regulate calcium flow. We have also shown that two types of NEUROPLASTIN protein (isoforms) are both expressed within the cochlea, although only one of these isoforms needs to be expressed for normal hearing. Finally, we also demonstrate that the hearing loss caused by the absence of Neuroplastin is made worse when combined with a common mutation within a gene called Cadherin 23 ( Cdh23 ahl ). This is an important finding as although there are currently no human patients with an identified NEUROPLASTIN mutation, it may be involved in human deafness in combination with other mutations.